Literature DB >> 12204949

Functional and phenotypic changes in circulating lymphocytes from hospitalized zambian children with measles.

Judith J Ryon1, William J Moss, Mwaka Monze, Diane E Griffin.   

Abstract

Measles is associated with immunosuppression and increased susceptibility to secondary infections and is a particular problem in developing countries. Lymphocyte changes accompanying immune activation and regulation of the immune response may contribute to immunosuppression. To evaluate lymphocyte changes during measles, children (n = 274) hospitalized with measles in Lusaka, Zambia, were evaluated at entry, discharge, and 1-month follow-up and compared to healthy Zambian children (n = 98). Lymphopenia was present on hospital admission and reflected decreased CD4 and CD8 T cells but resolved quickly. Lymphopenia was most marked in girls, in those with temperatures of >38.5 degrees C, and in malnourished children. CD4/CD8 ratios were decreased at all time points and were lower in boys than in girls at discharge and follow-up. Spontaneous death occurred in cultured lymphocytes, and the proportions of freshly isolated cells undergoing apoptosis, based on annexin V and propidium iodide staining, were increased. Surface Fas was increased on both CD4 and CD8 T cells compared to controls, and expression was greater on CD4 T cells and was inversely correlated with lymphocyte viability in culture at study entry. Mitogen stimulation of lymphocytes improved viability, but inhibitors of Fas, tumor necrosis factor (TNF)-related apoptosis-inducing ligand, and TNF did not. Plasma levels of beta(2) microglobulin and soluble Fas, Fas ligand, CD8, CD4, and TNF receptor were increased, and soluble CD8 was higher in boys than in girls. The multiple effects of measles on lymphocytes from Zambian children include decreased numbers in circulation, increased activation, and increased susceptibility to cell death, with substantive differences in the magnitude of these changes between boys and girls.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12204949      PMCID: PMC120077          DOI: 10.1128/cdli.9.5.994-1003.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  89 in total

1.  Apoptosis associated with ex vivo down-regulation of Bcl-2 and up-regulation of Fas in potential cytotoxic CD8+ T lymphocytes during HIV infection.

Authors:  F Boudet; H Lecoeur; M L Gougeon
Journal:  J Immunol       Date:  1996-03-15       Impact factor: 5.422

2.  Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing.

Authors:  I Cascino; G Fiucci; G Papoff; G Ruberti
Journal:  J Immunol       Date:  1995-03-15       Impact factor: 5.422

Review 3.  Immune responses during measles virus infection.

Authors:  D E Griffin
Journal:  Curr Top Microbiol Immunol       Date:  1995       Impact factor: 4.291

4.  Immunological unresponsiveness and apoptotic cell death of T cells in measles virus infection.

Authors:  M M Addae; Y Komada; X L Zhang; M Sakurai
Journal:  Acta Paediatr Jpn       Date:  1995-06

5.  Comparative analysis of apoptosis in HIV-infected humans and chimpanzees: relation with lymphocyte activation.

Authors:  M L Gougeon; H Lecoeur; J Heeney; F Boudet
Journal:  Immunol Lett       Date:  1996-06       Impact factor: 3.685

6.  An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro.

Authors:  G Papoff; I Cascino; A Eramo; G Starace; D H Lynch; G Ruberti
Journal:  J Immunol       Date:  1996-06-15       Impact factor: 5.422

7.  Growth factors can enhance lymphocyte survival without committing the cell to undergo cell division.

Authors:  L H Boise; A J Minn; C H June; T Lindsten; C B Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

8.  Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression.

Authors:  A N Akbar; N J Borthwick; R G Wickremasinghe; P Panayoitidis; D Pilling; M Bofill; S Krajewski; J C Reed; M Salmon
Journal:  Eur J Immunol       Date:  1996-02       Impact factor: 5.532

9.  Expression of the functional soluble form of human fas ligand in activated lymphocytes.

Authors:  M Tanaka; T Suda; T Takahashi; S Nagata
Journal:  EMBO J       Date:  1995-03-15       Impact factor: 11.598

10.  Control of CD4 effector fate: transforming growth factor beta 1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion.

Authors:  X Zhang; L Giangreco; H E Broome; C M Dargan; S L Swain
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307

View more
  31 in total

1.  Measles virus (MV) nucleoprotein binds to a novel cell surface receptor distinct from FcgammaRII via its C-terminal domain: role in MV-induced immunosuppression.

Authors:  David Laine; Marie-Claude Trescol-Biémont; Sonia Longhi; Geneviève Libeau; Julien C Marie; Pierre-Olivier Vidalain; Olga Azocar; Adama Diallo; Bruno Canard; Chantal Rabourdin-Combe; Hélène Valentin
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

2.  Canine distemper virus epithelial cell infection is required for clinical disease but not for immunosuppression.

Authors:  Bevan Sawatsky; Xiao-Xiang Wong; Sarah Hinkelmann; Roberto Cattaneo; Veronika von Messling
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

Review 3.  Immune containment and consequences of measles virus infection in healthy and immunocompromised individuals.

Authors:  Sallie R Permar; Diane E Griffin; Norman L Letvin
Journal:  Clin Vaccine Immunol       Date:  2006-04

4.  Immune activation and IL-12 production during acute/early HIV infection in the absence and presence of highly active, antiretroviral therapy.

Authors:  Adriana A Byrnes; David M Harris; Sowsan F Atabani; Beulah P Sabundayo; Susan J Langan; Joseph B Margolick; Christopher L Karp
Journal:  J Leukoc Biol       Date:  2008-09-19       Impact factor: 4.962

5.  In vitro suppression of human immunodeficiency virus type 1 replication by measles virus.

Authors:  Mayra García; Xiao-Fang Yu; Diane E Griffin; William J Moss
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing.

Authors:  Wen Wen; Wenru Su; Hao Tang; Wenqing Le; Xiaopeng Zhang; Yingfeng Zheng; Xiuxing Liu; Lihui Xie; Jianmin Li; Jinguo Ye; Liwei Dong; Xiuliang Cui; Yushan Miao; Depeng Wang; Jiantao Dong; Chuanle Xiao; Wei Chen; Hongyang Wang
Journal:  Cell Discov       Date:  2020-05-04       Impact factor: 10.849

7.  Association of persistent wild-type measles virus RNA with long-term humoral immunity in rhesus macaques.

Authors:  Ashley N Nelson; Wen-Hsuan W Lin; Rupak Shivakoti; Nicole E Putnam; Lisa Mangus; Robert J Adams; Debra Hauer; Victoria K Baxter; Diane E Griffin
Journal:  JCI Insight       Date:  2020-02-13

Review 8.  Measles virus persistence and its consequences.

Authors:  Diane E Griffin
Journal:  Curr Opin Virol       Date:  2020-05-05       Impact factor: 7.090

9.  Differential immune responses to primary measles-mumps-rubella vaccination in Israeli children.

Authors:  Bracha Rager-Zisman; Elina Bazarsky; Agneta Skibin; Guy Tam; Shlomo Chamney; Ilana Belmaker; Iris Shai; Ella Kordysh; Diane E Griffin
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

10.  Canine distemper virus selectively inhibits apoptosis progression in infected immune cells.

Authors:  Stéphane Pillet; Veronika von Messling
Journal:  J Virol       Date:  2009-04-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.